These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1379529)

  • 1. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage.
    Abraham E; Stevens P
    Crit Care Med; 1992 Aug; 20(8):1127-33. PubMed ID: 1379529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats.
    Attalah HL; Azoulay E; Yang K; Lasclos C; Jouault H; Soussy CJ; Guillot T; Brochard L; Brun-Buisson C; Harf A; Delclaux C
    Crit Care Med; 2002 Sep; 30(9):2107-14. PubMed ID: 12352049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor.
    O'Reilly M; Silver GM; Greenhalgh DG; Gamelli RL; Davis JH; Hebert JC
    J Trauma; 1992 Nov; 33(5):679-82. PubMed ID: 1281510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on defence effects of recombinant human granulocyte colony-stimulating factor (G-CSF) to infections. III. Protective effect on pulmonary and systemic infections of P. aeruginosa in neutropenic mice].
    Tomono K; Furuya N; Hirakata Y; Tateda K; Yamaguchi K; Morikawa N; Senju R; Kadota J; Kohno S; Hirota M
    Kansenshogaku Zasshi; 1990 May; 64(5):604-11. PubMed ID: 1698896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection.
    Silver GM; Gamelli RL; O'Reilly M
    Surgery; 1989 Aug; 106(2):452-5; discussion 455-6. PubMed ID: 2474866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
    Bauhofer A; Lorenz W; Kohlert F; Torossian A
    Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis.
    Haberstroh J; Wiese K; Geist A; Dursunoglu GB; Gippner-Steppert C; Jochum M; von Specht BU
    Shock; 1998 Feb; 9(2):128-34. PubMed ID: 9488258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
    Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
    Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice.
    Grossmann A; Lenox J; Deisher TA; Ren HP; Humes JM; Kaushansky K; Sprugel KH
    Blood; 1996 Nov; 88(9):3363-70. PubMed ID: 8896401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice.
    Tanaka T; Okamura S; Okada K; Suga A; Shimono N; Ohhara N; Hirota Y; Sawae Y; Niho Y
    Infect Immun; 1989 Jun; 57(6):1792-9. PubMed ID: 2656523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia.
    Abraham E; Robinson A
    Vaccine; 1991 Oct; 9(10):757-64. PubMed ID: 1759494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of ren-shen-yang-rong-tang (Ninjin-youei-to) in mice with drug-induced leukopenia against Pseudomonas aeruginosa infection.
    Miura S; Takimoto H; Yoshikai Y; Kumazawa Y; Yamada A; Nomoto K
    Int J Immunopharmacol; 1992 Oct; 14(7):1249-57. PubMed ID: 1280629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.